Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The … Continued
We hope everyone is keeping cool while feeling the warmth from our ovarian cancer community. And we hope to see many of your faces online this September when we host our … Continued
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients. Bioinformatics is a scientific discipline … Continued
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month. Below, we highlight breakthroughs in our understanding and treatment of ovarian cancer, thanks … Continued
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, … Continued
Audra Moran, President and CEO of OCRA, and Dr. Richard Pazdur, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer … Continued
There are so many ways to spring into action and knowledge around our shared mission. Read on to learn about promising research findings, how to make your voice heard, ways … Continued
Though palliative care and hospice care are both used to improve a patient’s quality of life, there are key distinctions between the two — as well as many commonly held … Continued
With tax season upon us, financial planning is on many people’s minds. While all gifts made by check or credit card are tax-deductible, there are other ways to fund cutting-edge … Continued
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases. This represents a major win for the ovarian cancer community, and we … Continued
Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr. Weigert aims to … Continued
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all … Continued
Get email updates about research news, action alerts, and ways to join the fight.
